Overview

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Clofarabine in combination with Busulfan is effective as a preparative transplant regimen for the treatment of leukemia and myelodysplastic syndromes
Phase:
Phase 2
Details
Lead Sponsor:
Baylor Research Institute
Collaborator:
Genzyme, a Sanofi Company
Treatments:
Busulfan
Clofarabine